# The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke

Study · id `cardio:ct-nct02580838` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02580838](<https://clinicaltrials.gov/study/NCT02580838>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02580838

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT02580838. Randomized; single masking; primary purpose treatment. Start 2015-08 (registry gives no type); primary completion 2023-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT02580838, source copy `cardio:ctgov-nct02580838-2022-09-30`, retrieved 2026-10-26)
- Start date: 2015-08 (registry gives no type) (ClinicalTrials.gov record NCT02580838, source copy `cardio:ctgov-nct02580838-2022-09-30`, retrieved 2026-10-26)
- Primary completion: 2023-09 (anticipated) (ClinicalTrials.gov record NCT02580838, source copy `cardio:ctgov-nct02580838-2022-09-30`, retrieved 2026-10-26)
- Completion: 2025-09 (anticipated) (ClinicalTrials.gov record NCT02580838, source copy `cardio:ctgov-nct02580838-2022-09-30`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT02580838, source copy `cardio:ctgov-nct02580838-2022-09-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02580838-2022-09-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke
- Condition: Stroke
- Intervention (Drug): OnabotulinumtoxinA
- Lead sponsor: National Cheng-Kung University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: National Cheng-Kung University Hospital (`cardio:org-national-cheng-kung-university-hospital`)

## Provenance

Content hash: a273ac3fecbac0a99bd8e76c5f4ffa5c179cefc71c438f888a4c3da0cb705fe0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
